TIRZEPATIDE

Tirzepatide 10mg

Tirzepatide operates by simultaneously targeting GLP-1 and glucagon receptors. It is reported to promote blood sugar regulation by enhancing insulin secretion in response to glucose, reducing glucagon production, slowing gastric emptying, and promoting satiety, in research subjects.

Its glucagon receptor activity also decreases glucose production in the liver and supports significant weight loss, setting Tirzepatide apart from traditional GLP-1 receptor agonists and potentially offering a novel approach to managing Type 2 diabetes mellitus (T2DM) and weight.

Tirzepatide peptide allegedly holds the ability to improve muscle growth and repair. This peptide may be helpful for the potential increase of physical performance in subjects.

Alchemi sells Tirzepatide for laboratory research use only.